oceanco702 - what you report is so very true!
Stepping back a few years, what got me so interetsed in SNDY many months back was the similarity to a Company I invested in a long time ago - Lifeline Biotechnologies (LLBT at the time). They too had a endoscope-type system that detected breast cancer very early.
The problem was, the initial results were showing so many "false positives", that the product had a hard time getting accepted.
It was not until years down the road that almost EVERY SINGLE "False Positive" was an early indication of cancer. The LLBT process was years ahead of others. Almost every patient that tested positive on LLBT later was diagnosed with breast cancer.
And today, I believe the SNDY process yields similar results.
The FDA already agrees we have a good product. In fact, 30 of them. Once the CE is obtained, the doors of the world open for SNDY. GLTY.
GLTA SNDY longs.